US Patent:
20130150258, Jun 13, 2013
Inventors:
The University of Chicago - Chicago IL, US
Bernard Roizman - Chicago IL, US
Andy Minn - Chicago IL, US
Nikolai Khodarev - Villa Park IL, US
Edwardine Labay - Des Plaines IL, US
Assignee:
The University of Chicago - Chicago IL
International Classification:
C12Q 1/68
Abstract:
Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.